1. Home
  2. GXO vs GRFS Comparison

GXO vs GRFS Comparison

Compare GXO & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GXO Logistics Inc.

GXO

GXO Logistics Inc.

HOLD

Current Price

$45.25

Market Cap

6.2B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.31

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GXO
GRFS
Founded
2021
1940
Country
United States
Spain
Employees
N/A
25247
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
4.9B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
GXO
GRFS
Price
$45.25
$7.31
Analyst Decision
Strong Buy
Hold
Analyst Count
11
2
Target Price
★ $67.91
$10.15
AVG Volume (30 Days)
★ 1.2M
385.3K
Earning Date
05-05-2026
07-28-2022
Dividend Yield
N/A
★ 1.80%
EPS Growth
N/A
★ N/A
EPS
★ 0.25
N/A
Revenue
★ $13,178,000,000.00
N/A
Revenue This Year
$6.81
$4.49
Revenue Next Year
$5.95
$6.42
P/E Ratio
$176.68
★ $18.67
Revenue Growth
★ 12.55
N/A
52 Week Low
$43.61
$6.96
52 Week High
$66.85
$10.23

Technical Indicators

Market Signals
Indicator
GXO
GRFS
Relative Strength Index (RSI) 43.25 40.94
Support Level N/A $7.33
Resistance Level $48.40 $8.41
Average True Range (ATR) 1.40 0.11
MACD -0.07 -0.03
Stochastic Oscillator 32.72 25.00

Price Performance

Historical Comparison
GXO
GRFS

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: